标题
The role of telomeres and telomerase in cirrhosis and liver cancer
作者
关键词
-
出版物
Nature Reviews Gastroenterology & Hepatology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-29
DOI
10.1038/s41575-019-0165-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas
- (2018) Jean-Charles Nault et al. HEPATOLOGY
- Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma
- (2018) Eunkyong Ko et al. HEPATOLOGY
- Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations
- (2018) Peter Chianchiano et al. HUMAN PATHOLOGY
- Hepatic manifestations of telomere biology disorders
- (2018) Mrinal M. Patnaik et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
- (2018) Ismail Labgaa et al. ONCOGENE
- Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
- (2018) Anqiang Wang et al. Nature Communications
- Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma
- (2018) Julien Calderaro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
- (2018) Quentin Bayard et al. Nature Communications
- Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
- (2017) Jean-Charles Nault et al. GASTROENTEROLOGY
- Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
- (2017) Sara Torrecilla et al. JOURNAL OF HEPATOLOGY
- TERTbiology and function in cancer: beyond immortalisation
- (2017) Ana Pestana et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma
- (2017) Li-Jie Ma et al. JOURNAL OF PATHOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
- (2017) Hye Won Lee et al. MEDICINE
- Systematic analysis of telomere length and somatic alterations in 31 cancer types
- (2017) Floris P Barthel et al. NATURE GENETICS
- Identification of liver-specific enhancer–promoter activity in the 3′ untranslated region of the wild-type AAV2 genome
- (2017) Grant J Logan et al. NATURE GENETICS
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
- (2017) Eric Letouzé et al. Nature Communications
- Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
- (2017) Jeong Il Yu et al. Scientific Reports
- Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
- (2016) Dengke Bao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
- (2016) Ruidong Xue et al. GASTROENTEROLOGY
- Genetic profiling of hepatocellular carcinoma using next-generation sequencing
- (2016) Kornelius Schulze et al. JOURNAL OF HEPATOLOGY
- Mechanisms of HBV-induced hepatocellular carcinoma
- (2016) Massimo Levrero et al. JOURNAL OF HEPATOLOGY
- A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2016) Ralph Salloum et al. JOURNAL OF NEURO-ONCOLOGY
- Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
- (2016) Ling-Hao Zhao et al. Nature Communications
- Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma
- (2016) Francesca Pezzuto et al. Oncotarget
- Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States
- (2016) Baiyu Yang et al. PLoS One
- Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney
- (2015) Jenny Karlsson et al. CANCER LETTERS
- Hepatopulmonary Syndrome Is a Frequent Cause of Dyspnea in the Short Telomere Disorders
- (2015) Amany I. Gorgy et al. CHEST
- Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion
- (2015) J. K. Meena et al. EMBO JOURNAL
- Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
- (2015) Dong-Sheng Huang et al. EUROPEAN JOURNAL OF CANCER
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
- (2015) Jean-Claude Trinchet et al. HEPATOLOGY
- Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features
- (2015) Fukiko Kawai-Kitahata et al. JOURNAL OF GASTROENTEROLOGY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
- (2015) Jean-Charles Nault et al. NATURE GENETICS
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
- (2015) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
- (2015) Gabriela M. Baerlocher et al. NEW ENGLAND JOURNAL OF MEDICINE
- TERTpromoter mutations and telomerase reactivation in urothelial cancer
- (2015) Sumit Borah et al. SCIENCE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations
- (2015) Dilek Cevik WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study
- (2015) Roula Tahtouh et al. PLoS One
- A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
- (2014) A. A. Chiappori et al. ANNALS OF ONCOLOGY
- Pathogenesis of hepatocellular carcinoma according to aetiology
- (2014) Jean-Charles Nault BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
- (2014) Camilla Pilati et al. CANCER CELL
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
- (2014) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- Cellular senescence: from physiology to pathology
- (2014) Daniel Muñoz-Espín et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular Profiling of Liver Tumors: Classification and Clinical Translation for Decision Making
- (2014) Roser Pinyol et al. SEMINARS IN LIVER DISEASE
- Frequency of TERT promoter mutations in primary tumors of the liver
- (2014) Alexander Quaas et al. VIRCHOWS ARCHIV
- TERT promoter mutation in resectable hepatocellular carcinomas: A strong association with hepatitis C infection and absence of hepatitis B infection
- (2014) Yu-Ling Chen et al. International Journal of Surgery
- Advanced precancerous lesions in the liver
- (2013) Luca Di Tommaso et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- High Incidence of ActivatingTERTPromoter Mutations in Meningiomas Undergoing Malignant Progression
- (2013) Stéphane Goutagny et al. BRAIN PATHOLOGY
- TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
- (2013) K G Griewank et al. BRITISH JOURNAL OF CANCER
- A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
- (2013) Daniela Fenoglio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Role of Telomeres in Stem Cells and Cancer
- (2013) Cagatay Günes et al. CELL
- TERT promoter mutations in cancer development
- (2013) Barbara Heidenreich et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
- (2013) Yves Allory et al. EUROPEAN UROLOGY
- Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B
- (2013) Seok Won Jung et al. HEPATOLOGY
- Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing “stemness”-related markers
- (2013) Haeryoung Kim et al. JOURNAL OF HEPATOLOGY
- Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features
- (2013) Laura D Wood et al. MODERN PATHOLOGY
- TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
- (2013) Klaus G Griewank et al. MODERN PATHOLOGY
- Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma
- (2013) A Tallet et al. ONCOGENE
- Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease
- (2013) Aloysious Aravinthan et al. PLoS One
- TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
- (2013) Klaus G. Griewank et al. PLoS One
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization
- (2012) Han-Qiang Liu et al. CARCINOGENESIS
- Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: A clue to telomere involvement
- (2012) Lucia Carulli et al. HEPATOLOGY
- Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis
- (2012) Yvonne Begus-Nahrmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease
- (2012) Aloysious Aravinthan et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
- (2012) Akihiro Fujimoto et al. NATURE GENETICS
- Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
- (2012) Wing-Kin Sung et al. NATURE GENETICS
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
- (2012) Courtney A. Lovejoy et al. PLoS Genetics
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
- (2011) Christopher M. Heaphy et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
- (2011) A. Kotsakis et al. ANNALS OF ONCOLOGY
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- Constitutional telomerase mutations are genetic risk factors for cirrhosis
- (2011) Rodrigo T. Calado et al. HEPATOLOGY
- Telomerase gene mutations are associated with cirrhosis formation
- (2011) Daniel Hartmann et al. HEPATOLOGY
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
- (2011) Camilla Pilati et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
- (2011) Jean Charles Nault et al. JOURNAL OF HEPATOLOGY
- Is telomerase a viable target in cancer?
- (2011) C.M. Buseman et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Telomere dysfunction induces metabolic and mitochondrial compromise
- (2011) Ergün Sahin et al. NATURE
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- Genetics of Hepatobiliary Carcinogenesis
- (2011) Jean-Charles Nault et al. SEMINARS IN LIVER DISEASE
- Revisiting the Pathology of Resected Benign Hepatocellular Nodules Using New Immunohistochemical Markers
- (2011) Paulette Bioulac-Sage et al. SEMINARS IN LIVER DISEASE
- Mechanisms of HBV-related hepatocarcinogenesis
- (2010) Christine Neuveut et al. JOURNAL OF HEPATOLOGY
- Ageing, telomeres, senescence, and liver injury
- (2010) Matthew Hoare et al. JOURNAL OF HEPATOLOGY
- Linking functional decline of telomeres, mitochondria and stem cells during ageing
- (2010) Ergün Sahin et al. NATURE
- Alternative lengthening of telomeres: models, mechanisms and implications
- (2010) Anthony J. Cesare et al. NATURE REVIEWS GENETICS
- 2009 Nobel Prize in Physiology or Medicine: telomeres and telomerase
- (2010) E Varela et al. ONCOGENE
- Telomeres and telomerase in cancer
- (2009) S. E. Artandi et al. CARCINOGENESIS
- Telomere Dysfunction and DNA Damage Checkpoints in Diseases and Cancer of the Gastrointestinal Tract
- (2009) K. Lenhard Rudolph et al. GASTROENTEROLOGY
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- Telomerase modulates Wnt signalling by association with target gene chromatin
- (2009) Jae-Il Park et al. NATURE
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Telomere Diseases
- (2009) Rodrigo T. Calado et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice
- (2008) Ying Zhang et al. LIFE SCIENCES
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now